Research Note: Published preclinical research, including a 2025 literature and patent review in the journal Pharmaceuticals (Jzwiak et al., 2025, Pharmaceuticals ), has documented BPC-157's effects on angiogenesis, nitric oxide signaling, and tissue protection in animal models, though authors note that no completed human clinical trials have been published to confirm these effects in people
Patient adherence data consistently shows that less frequent dosing improves compliance one reason the field has moved toward longer-acting formulations
Inform your representatives
No perceptible effect (18-22% of reviews) A significant minority report zero subjective benefit
BPC-157: the gastric-derived pentadecapeptide BPC-157 (Body Protection Compound-157) is a stable synthetic pentadecapeptide of 15 amino acids, originally isolated from a larger protective protein found in gastric juice
This stimulation in turn is the basis for its effects confirmed in various studies in animals and humans